Global Canine Arthritis Treatment Market 2019-2023

The canine arthritis treatment market will grow by USD 498 million during 2019-2023. The industry analysis report offers an analysis of the market based on product segmentation including NSAIDS, opioids, and others. The canine arthritis treatment market research report further present in-depth insights on the growth prospects of the market across geographic regions including the Americas, APAC, and EMEA. The report also provides an analysis of the market’s competitive landscape and offers information on several companies including Bayer, Boehringer Ingelheim, and Eli Lily.

Want to get a preview about how you can gain valuable insights from Technavio’s market research report? Check out the latest facts about the canine arthritis treatment industry

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

 Get a FREE sample now!

The global canine arthritis treatment market is expected to grow at a CAGR of almost 4% during the forecast period

Canine arthritis treatment industry growth is expected to accelerate over the next five years, driven by growing consolidation in the industry. Strategic alliances such as mergers, acquisitions, and collaborations help in co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertise which is expected to boost the growth of the global canine arthritis treatment market. Also, smaller companies who offer arthritis treatment for dogs are increasing option for M&A for complete development of drugs and consolidate their market position. Technavio’s canine arthritis treatment industry analysis reveals promising markets around the world.

The Americas dominated the canine arthritis treatment market by region

The global canine arthritis treatment market was dominated by the Americas with a market share of over 46%, followed by EMEA and APAC. However, APAC is expected to witness a faster growth than EMEA and the Americas over the period of forecast. In addition, the Americas will drive around 44% of the growth for the arthritis treatment for dogs industry, while EMEA and APAC are also predicted to contribute significantly to the incremental growth in the forecast period.

Bayer, Boehringer Ingelheim, and Eli Lily are among the leading canine arthritis treatment vendors

The global canine arthritis treatment market is forecasted to grow reasonably fragmented with the existence of many international and regional vendors who offer arthritis treatment for dogs. Most of the established companies in the global canine arthritis treatment market are focused on conducting extensive research on the treatment of life-threatening disorders by using stem cell therapy. Many international and regional vendors are vying for their share of the global canine arthritis treatment market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

• Bayer
• Boehringer Ingelheim
• Eli Lilly
• Vetoquinol
• Zoetis

We can help! Our analysts can customize this report to meet your requirements. Get in touch